Quick-Med Technologies, Inc. (OTCBB:QMDT) announced that the company will participate in the Third Congress of the World Union of Wound Healing Societies being held in Toronto, Ontario on June 4-8, 2008.
Three poster abstracts have been accepted for presentation:
"Absorbent Microbicidal Wound Dressing Material with Protease Inhibitor Properties"- B. Liesenfeld, G. Schultz, J. Azeke, O. Moloye, W. Toreki, D. Moore, J. Olderman and R. Carr; Quick-Med Technologies, Inc. and the University of Florida at Gainesville.
"Protease Inhibitors Prevent Microvesication in Sulfur Mustard Wounds on Human Skin Explant" - B. Liesenfield, M. Mol and G. Schultz; Quick-Med Technologies, Inc., TNO Laboratories, Netherlands and the University of Florida at Gainesville.
"Persistent Skin Sanitizer with Sustained Microbicidal Properties" -Â W. Toreki, D. Moore, B. Liensenfield, J. Vella, G. Schultz, J. Olderman and R. Carr; Quick-Med Technologies, Inc. and the University of Florida at Gainesville.
"We are pleased to have our NIMBUS®, NimbuDermâ„¢ and MultiStatâ„¢ technologies selected for presentation at this prestigious wound care event," said J. Ladd Greeno, Chief Executive Officer of Quick-Med Technologies.
Quick-Med Technologies is developing advanced solutions for wound care market. Wound care is a $10 billion market, with continued growth being driven by an aging population, the rise in the incidence of diabetes worldwide, and a steady advancement in more clinically efficient and cost-effective technology and products.
To schedule a meeting with Quick-Med Technologies, please contact Roy D. Carr, Director of Business Development - Medical Devices at 561-771-1306, or rcarr@quickmedtech.com.
About Third Congress of the World Union of Wound Healing Societies
The primary goal of the World Union of Wound Healing Societies 2008 Congress, sponsored and hosted by the University of Toronto, will be to present the wound care evidence base and transfer the knowledge, skills, and attitudes for improved patient outcomes. This will be accomplished through a five-day meeting that includes a pre-conference day, three plenary sessions, and 10 concurrent streams with more than 100 educational sessions. For more information, see: www.wuwhs2008.com.
About Quick-Med Technologies, Inc.
Quick-Med Technologies, Inc. is a life sciences company that is developing innovative technologies for the healthcare and consumer markets. For more information, see: www.quickmedtech.com.
© 2008 Quick-Med Technologies, Inc. All rights reserved. NIMBUS® is a registered trademark and NimbuDermâ„¢ and MultiStat are trademarks of Quick-Med Technologies, Inc.
Forward-looking statements (statements which are not historical facts) in this release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For this purpose, any statements contained in this release that are not statements of historical fact may be deemed to be forward-looking statements. Without limiting the generality of the foregoing, words such as "may", "will", "to", "expect", "plan", "believe", "anticipate", "intend", "could", "would", "estimate", and/or "continue" or the negative or other variations thereof or comparable terminology is intended to identify forward-looking statements involve risks and uncertainties, including those risks that are discussed in the Company's filings with the Securities and Exchange Commission ("SEC"), which may be accessed at the SEC's Edgar System at www.sec.gov.
